Tibet Weixinkang Medicine Co., Ltd. (603676.SS) SHH
9.33
-0.22(-2.30%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.54B |
| Enterprise Value | 4.33B |
| P/E Ratio | 18.39 |
| PEG Ratio | -2.02 |
| Price/Sales Ratio | 3.47 |
| Price/Book Ratio | 2.58 |
| Enterprise/Revenue | 3.25 |
| Enterprise/EBITDA | 12.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.19 |
| Operating Margin | 0.24 |
Management Effectiveness
| Return On Assets | 0.11 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 1.14B |
| Revenue/Share | 2.72 |
| Gross Profit | 697.94M |
| EBITDA | 334.69M |
| Net Income | 232.85M |
| Diluted EPS | 0.54 |
Balance Sheet
| Total Cash | 1.05B |
| Total Cash/Share | 2.46 |
| Total Debt | 5.33M |
| Total Debt/Equity | 0 |
| Current Ratio | 3.74 |
| Book Value Per Share | 3.62 |
Price History
| 52-Week Change | -18.8 |
| 52-Week High | 14.94 |
| 52-Week Low | 9.08 |
| Moving Average 50 Days | 10.27 |
| Moving Average 200 Days | 11.12 |
Statistics
| Average Volume | 2.02M |
| Shares Outstanding | 432.33M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.33 |
| Trailing Annual Dividend Yield | 3.5 |
| Payout Ratio | 0.69 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
